Performance Measure Portfolio

The HIV/AIDS Bureau performance measure portfolio focuses on critical areas of HIV care and treatment, and aligns with milestones along the HIV care continuum. The performance measure portfolio focuses on:

  • Identifying core performance measures that are most critical to the care and treatment of people with HIV
  • Combining performance measures to address people of all ages with HIV
  • Promoting relevant performance measures used in other federal programs
  • Archiving performance measures that are no longer consistent with U.S. Department of Health and Human Services guidelines or applicable to the general population

The HIV/AIDS Bureau encourages Ryan White HIV/AIDS Program recipients to use the revised performance measures, including the core performance measures. The core performance measures completed the rigorous National Quality Forum infectious disease endorsement process HRSA Exit Disclaimer.

Given the emphasis on using performance measures to improve health of people with HIV, recipients may trend performance measure data over time and analyze the data for disparities in care. Disparity analyses may include review data for difference in performance in gender, race/ethnicity, age, insurance status, HIV risk, and others.

Use of Technology to Provide Services

HRSA's HIV/AIDS Bureau performance measures often include a medical visit in numerator or denominator.  A medical visit is an encounter between a patient and a provider with prescribing privileges (such as a physician, nurse practitioner, or physician assistant). A medical visit can occur face-to-face, via telehealth, and in other settings.  HIV/AIDS Bureau Policy Clarification Notice #16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals & Allowable Uses of Funds (PDF - 173 KB) states HRSA's Ryan White HIV/AIDS Program recipients are encouraged to consider all methods or means by which they can provide services, including use of technology (e.g., telehealth); and Outpatient/Ambulatory Health Services settings may include: clinics, medical offices, mobile vans, using telehealth technology, and urgent care facilities for HIV-related visits.

The revised performance measure portfolio is outlined below.

Performance Measures and Frequently Asked Questions



Frequently Asked Questions:

  • General Information
  • Revised Portfolio
  • Children
  • Oral Health
  • ADAP
  • System
  • Adolescent/Adult

General FAQ (PDF – 44 KB)

Revised Measures FAQ (PDF – 194 KB)

Children FAQ (PDF – 66 KB)

Oral Health FAQ (PDF – 38 KB)


System FAQ (PDF – 51 KB)

Adolescent/Adult FAQ (PDF – 175 KB)

  • HIV Viral Suppression
  • Prescription of HIV Antiretroviral Therapy
  • HIV Medical Visit Frequency
  • Gap in HIV Medical Visits
  • PCP Prophylaxis
  • Annual Retention in Care


Core Measures (PDF – 358 KB)

All Ages:

  • HIV Drug Resistance Testing Before Initiation of Therapy
  • Influenza Immunization
  • Lipid Screening
  • Tuberculosis Screening


All Ages Measures (PDF – 234 KB)


  • Cervical Cancer Screening
  • Chlamydia Screening
  • Gonorrhea Screening
  • Hepatitis B Screening
  • Hepatitis B Vaccination
  • Hepatitis C Screening
  • HIV Risk Counseling
  • Oral Exam
  • Pneumococcal Vaccination
  • Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
  • Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • Substance Abuse Screening
  • Syphilis Screening


Adolescent and Adult Measures (PDF – 369 KB)


  • MMR Vaccination


Children Measures (PDF – 162 KB)

HIV-Exposed Children:

  • Diagnostic Testing to Exclude HIV Infection in Exposed Infants
  • Neonatal Zidovudine Prophylaxis
  • PCP Prophylaxis for HIV-Exposed Infants


HIV Exposed Children Measures (PDF – 220 KB)


Medical Case Management (MCM):

  • Care Plan
  • Gap in HIV Medical Visits
  • HIV Medical Visit Frequency


MCM Measures (PDF – 231 KB)


Oral Health:

  • Dental and Medical History
  • Dental Treatment Plan
  • Oral Health Education
  • Periodontal Screening or Examination
  • Phase I Treatment Plan Completion


Oral Health Measures (PDF – 254 KB)


  • Application Determination
  • Eligibility Recertification
  • Formulary
  • Inappropriate Anti-Retroviral Regimen


ADAP Measures (PDF – 281 KB)


  • Waiting Time for Initial Access to Outpatient/Ambulatory Medical Care
  • HIV Test Results for People Living with HIV
  • HIV Positivity
  • Late HIV Diagnosis
  • Linkage to HIV Medical Care
  • Housing Status


System Measures (PDF – 271 KB) 

Archived Performance Measure Downloads


Date Last Reviewed:  June 2020